The Current Ratio as of November 2024 (TTM) for Rigel Pharmaceuticals, Inc. (RIGL) is 1.62

According to Rigel Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 1.62. This represents a change of -3.73% compared to the average of 1.68 of the last 4 quarters.

Rigel Pharmaceuticals, Inc. (RIGL) Historical Current Ratio (quarterly & annually)

How has RIGL Current Ratio performed in the past?

The mean historical Current Ratio of Rigel Pharmaceuticals, Inc. over the last ten years is 3.96. The current 1.62 Current Ratio has changed 3.98% with respect to the historical average. Over the past ten years (40 quarters), RIGL's Current Ratio was at its highest in in the September 2014 quarter at 15.58. The Current Ratio was at its lowest in in the March 2024 quarter at 1.26.

Rigel Pharmaceuticals, Inc. (RIGL) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Rigel Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Rigel Pharmaceuticals, Inc. (RIGL) Average Current Ratio

How has RIGL Current Ratio performed in the past?

The current Current Ratio of Rigel Pharmaceuticals, Inc. (RIGL) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Rigel Pharmaceuticals, Inc. (RIGL) Current Ratio vs. Peers

How is RIGL’s Current Ratio compared to its peers?

Rigel Pharmaceuticals, Inc.’s Current Ratio is greater than Fortress Biotech, Inc. (1.37), greater than Reviva Pharmaceuticals Holdings, Inc. (0.41), greater than CTI BioPharma Corp. (1.27), less than Ocuphire Pharma, Inc. (10.68), greater than Nabriva Therapeutics plc (0.85), greater than Eiger BioPharmaceuticals, Inc. (0.71), less than Pieris Pharmaceuticals, Inc. (3.95), less than Cidara Therapeutics, Inc. (4.25), less than X4 Pharmaceuticals, Inc. (6.07), less than Mereo BioPharma Group plc (6.07), less than Inozyme Pharma, Inc. (9.84), less than Terns Pharmaceuticals, Inc. (21.02), less than Leap Therapeutics, Inc. (5.10), less than Zura Bio Limited (12.57), less than Enveric Biosciences, Inc. (7.37), greater than eFFECTOR Therapeutics, Inc. (1.03), less than Immix Biopharma, Inc. (7.00), less than Elevation Oncology, Inc. (41.10), less than Day One Biopharmaceuticals, Inc. (14.62), less than Acumen Pharmaceuticals, Inc. (17.37), less than VectivBio Holding AG (9.14),

Build a custom stock screener for Rigel Pharmaceuticals, Inc. (RIGL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Rigel Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Rigel Pharmaceuticals, Inc. (RIGL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Rigel Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.